The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Written and directed by Jesse Eisenberg, the film follows two relatives as they make a pilgrimage to their grandmother’s home ...

Investors can’t stop talking about the $10 million milestone that Remittix reached in only fourteen days. Remittix is in its ...

A man who partially-blinded his partner in a "horrific" attack has been jailed for almost three years. John Walker, 56, threw ...